Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection

Reactivation of latent cytomegalovirus (CMV) endangers the therapeutic success of hematopoietic cell transplantation (HCT) in tumor patients due to cytopathogenic virus spread that leads to organ manifestations of CMV disease, to interstitial pneumonia in particular. In cases of virus variants that...

Descripción completa

Detalles Bibliográficos
Autores principales: Gergely, Kerstin M., Podlech, Jürgen, Becker, Sara, Freitag, Kirsten, Krauter, Steffi, Büscher, Nicole, Holtappels, Rafaela, Plachter, Bodo, Reddehase, Matthias J., Lemmermann, Niels A. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416627/
https://www.ncbi.nlm.nih.gov/pubmed/34489940
http://dx.doi.org/10.3389/fimmu.2021.694588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416627/
https://www.ncbi.nlm.nih.gov/pubmed/34489940
http://dx.doi.org/10.3389/fimmu.2021.694588

Ejemplares similares